Cervical cancer, human papillomavirus, and vaccination

Abstract

Footnotes Competing interests None declared References ↵ Merck Newsroom . Merck's investigational vaccine GARDASIL TM prevented 100 per cent of cervical pre-cancers and non-invasive cervical cancers associated with HPV types 16 and 18 in new clinical study. Press release 6 Oct 2005. http://www.merck.com/newsroom/press_releases/research_and_development/2005_1006.html (acccessed 17 Oct 2005). ↵ World Health Organization . WHO consultation on human papillomavirus vaccines. Wkly Epidemiol Rec 2005; 80: 299301. ↵ Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al . A controlled trial of human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 164551. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al . Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004; 364: 175765. ↵ Villa LL, Costa RLR, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al . Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6: 2718. ↵ Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 24465. ↵ Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 51827. ↵ Parkin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108. ↵ Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJF, Vaccarella S, et al . Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 9918. ↵ Peto J, Gilham C, Fletcher O, Matthews FE . The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004; 364: 24956. ↵ NHS Cervical Cancer Screening Programme . Cervical cancer—incidence, mortality and risk factors. http://www.cancerscreening.nhs.uk/cervical/risks.html (acccessed 17 Oct 2005). ↵ UK Collaborative Group for HIV and STI Surveillance . Focus on prevention. HIV and other sexually transmitted infections in the United Kingdom in 2003. London: Health Protection Agency Centre for Infections, 2004. http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/publications/annual2004/annual2004.htm (acccessed 17 Oct 2005). ↵ Johnson AM, Mercer CH, Erens R, Copas AJ, McManus S, Wellings K, et al . Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001; 358: 183542. ↵ International Finance Facility for Immunisation . New International Finance Facility for Immunisation Could Save 10 Million Lives. Press release 9 Sep 2005. http://www.iffim.com/05_090905_02_eng.html (acccessed 17 Oct 2005).